Novartis sees core operating income to grow mid single digit percentage in 2023

Novartis’ 2023 guidance: "Group expected to grow sales low-to-mid single digit and core operating income mid single digit. IM expected to grow sales low-to-mid single digit and core operating income mid-to-high single digit." The company previously announced an up-to $15B share buyback is ongoing, noting that $4.9B is still to be executed. A dividend of CHF 3.20 per share, an increase of 3.2%, is proposed for 2022.